Annexin Pharmaceuticals to Present at Investing in Life Science on September 22
The 4th edition of Investing in Life Science takes place on September 22 in Stockholm. Anders Haegerstrand, CEO will present Annexin Pharmaceuticals to specialist life science investors and potential strategic partners.Investing in Life Science serves as a dedicated platform connecting innovation w…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.